Compounding Pharmacy Products and Services at MEDISCA

Analgesic Compounding Laboratory Training

This laboratory training aims to expose pharmacists and technicians to the hands-on experience of compounding dosage forms common to the niche market of analgesic therapy, notably creams, gels, and pastes. Participants will learn how to optimize the efficiency and quality of their compounding process by practicing novel compounding techniques and implementing innovative technologies and equipment.

No account yet? Register here to access.

ACTIVITY DESCRIPTION

As it stands today, first-line treatments for pain management are often associated with adverse systemic effects, including gastrointestinal erosions, constipation, central nervous system depression, addiction, and tolerance. Moreover, many currently available commercial analgesics are limited in therapeutic efficacy, rendering many pain symptoms left untreated or inadequately managed. With compounded topical creams and gels, patients can better target the site of action through local application to affected regions, limiting systemic reactions and in many cases, improving therapeutic outcomes. In addition, compounders can develop low-dose multi-drug formulations that reach multiple nociceptive pathways, further optimizing targeted effect and ultimately therapeutic payoff.

FEATURED FORMULAS

Clonidine HCl 0.16%, Gabapentin 6%, Ketamine† HCl 5.75 % Topical Cream
Diclofenac Sodium 5% Topical Gel
Capsaicin 0.025%, Lidocaine 6%, Tetracaine 4% Dental Paste

Note: Formulas are subject to change.
Controlled substances will be replaced by non-controlled substances.

DURATION: 4 HOURS

COMPLETION REQUIREMENTS

Full attendance and participation are required to receive a Certificate of Attainment.

DECLARATIONS AND DISCLOSURES

This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA AUSTRALIA ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.

FINANCIAL SUPPORT

This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.